Serum klotho and FGF23 Levels in Patients with Schizophrenia

KAZĞAN KILIÇASLAN A., YILDIZ S., Emir B. S., KILIÇ F., ATMACA M.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, vol.32, no.3, pp.229-236, 2022 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.5152/pcp.2022.22406
  • Journal Name: PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.229-236
  • Keywords: Fibroblast growth factor 23, inflammation, klotho, schizophrenia, serum, CEREBROSPINAL-FLUID, VITAMIN-D, COGNITION, DEPRESSION, RELEASE, MODEL
  • Süleyman Demirel University Affiliated: Yes

Abstract

Background: The aim of this study is to compare the serum levels of Klotho and fibroblast growth factor 23 in patients with schizophrenia, in whom etiopathogenesis inflammation plays an important role, with those of healthy control subjects and to investigate a possible correlation between these levels.